title: Sertraline-induced ventricular tachycardia.
abstract: Sertraline is a selective serotonin reuptake inhibitor, which is a commonly used drug for major depressive disorder. Most frequently reported adverse effects of sertraline in patients receiving 50-150 mg/d are dry mouth, headache, diarrhea, nausea, vomiting, sweating, and dizziness. We hereby report one of the few cases of sertraline-induced ventricular tachycardia, which has been for the first time objectively assessed by the Naranjo scale. We therefore urge the primary care physicians and the cardiologists to keep sertraline as a possible precipitating factor for evaluation of ventricular tachycardia.
authors.affiliation: Departments of 1Internal Medicine and 2Cardiovascular Disease, University of Oklahoma Health Science Center, Oklahoma City, OK.
authors.forename: Nishit H
authors.initials: NH
authors.lastname: Patel
authors.forename: Harsh
authors.initials: H
authors.lastname: Golwala
authors.forename: Stavros
authors.initials: S
authors.lastname: Stavrakis
authors.forename: Eliot
authors.initials: E
authors.lastname: Schechter
mesh_terms: D003865:Major Depressive Disorder / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D020280:Sertraline / Q000009:adverse effects* / Q000627:therapeutic use; D017180:Tachycardia, Ventricular / Q000139:chemically induced*
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline